<DOC>
	<DOCNO>NCT00978978</DOCNO>
	<brief_summary>Prospective , randomized-controlled trial ( RCT ) compare use Propofol traditional sedation ( Midazolam Fentanyl ) diagnostic screen endoscopy patient liver disease . The investigator ' work hypothesis use propofol translate short recovery discharge time higher patient satisfaction decrease general complication context patient advance liver disease .</brief_summary>
	<brief_title>Propofol Versus Midazolam Fentanyl Diagnostic Screening Colonoscopy Patients With Advanced Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Consecutive patient older 18 young 75 year advance liver disease , define presence liver fibrosis least F3 high METAVIR score establish cirrhosis ( Child Pugh A , B C ) Patients significant cardiorespiratory disease i.e . advanced respiratory , renal heart failure ( ASA class III high except patient decompensate liver cirrhosis ) , obstructive sleep apnea mild degree liver fibrosis ( less F3 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>